Fredun Pharmaceuticals has been awarded a tender by the Tamil Nadu Medical Services Corporation (TNMSC) for the supply of generic medicines. The total value of the tender ranges between Rs 15 crore and Rs 18 crore. The supply of these goods is set to commence within the first quarter of FY26 and will extend over a period of 14 months.
The products will be part of the Fredun Gx brand, which is known for its dedication to excellence and reliability. This tender award from TNMSC not only reinforces its position in the market but also aligns with its mission to enhance access to essential medications for all.
Fredun Pharmaceuticals is engaged in manufacturing of pharmaceutical products.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1665.25 |
| Dr. Reddys Lab | 1220.75 |
| Cipla | 1232.90 |
| Zydus Lifesciences | 928.85 |
| Lupin | 2311.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: